Table 2.
Mental Fatigue | Placebo | Carbohydrate | |
---|---|---|---|
RERMAX | 1.16 ± 0.06 | 1.17 ± 0.07 | 1.16 ± 0.07 |
RPEMAX | 19.40± 0.99 | 19.42 ± 1.50 | 19.79 ± 0.54 |
RPESLOPE | 0.91 ± 0.21 | 0.92 ± 0.18 | 0.88 ± 0.16 |
VT1 (W) | 225.21 ± 25.55 | 242.43 ± 25.48 | 237.73 ± 17.52 |
VT2 (W) | 283.59 ± 29.01 | 297.26 ± 26.63 | 297.92 ± 19.69 |
VT1 (% WPEAK) | 64.62 ± 5.77 | 70.35 ± 5.49 | 66.78 ± 7.09 |
VT2 (% WPEAK) | 82.33 ± 6.79 | 86.24 ± 4.32 | 84.40 ± 3.39 |
VT1 (L/min) | 3.07 ± 0.39 | 3.30 ± 0.40 | 3.12 ± 0.40 |
VT2 (L/min) | 3.73 ± 0.39 | 3.82 ± 0.38 | 3.85 ± 0.23 |
VT1 (% VO2PEAK) | 70.87 ± 7.95 | 74.78 ± 8.31 | 71.57 ± 8.70 |
VT2 (% VO2PEAK) | 85.71 ± 4.71 | 87.13 ± 5.12 | 90.20 ± 4.69 |
There was a main condition effect (mental fatigue vs. placebo) for VT expressed as %WPEAK.